Cohen Capital Management, Inc. Biogen Inc. Transaction History

Cohen Capital Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $161,222 - $207,194	-720 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$242.95 - $284.63 $174,924 - $204,933	720 New	720 $201,000
Q4 2020 Feb 03, 2021	SELL	$236.26 - $355.63 $170,107 - $256,053	-720 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$264.77 - $305.71 $190,634 - $220,111	720 New	720 $204,000
Q2 2020 Jul 31, 2020	SELL	$258.66 - $342.55 $186,235 - $246,636	-720 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$268.85 - $341.04 $16,131 - $20,462	60 Added 9.09%	720 $228,000
Q4 2019 Feb 05, 2020	BUY	$220.06 - $304.07 $145,239 - $200,686	660 New	660 $196,000
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $143,028 - $223,713	-660 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$278.5 - $352.75 $16,710 - $21,165	60 Added 10.0%	660 $199,000
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $176,106 - $230,298	600 New	600 $212,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cohen Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Cohen Capital Management, Inc. with notifications on news.